World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 10 May 2021
Main ID:  NCT04069429
Date of registration: 27/07/2019
Prospective Registration: No
Primary sponsor: University of Utah
Public title: Radiation Dose in Humans From Orally Administered Tc99m-Heparin
Scientific title: Radiation Dose in Humans From Orally Administered Tc99m-Heparin
Date of first enrolment: July 2016
Target sample size: 8
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT04069429
Study type:  Interventional
Study design:  Allocation: Non-Randomized. Intervention model: Parallel Assignment. Primary purpose: Basic Science. Masking: None (Open Label).  
Phase:  Early Phase 1
Countries of recruitment
United States
Contacts
Name:     Gerald Gleich, MD
Address: 
Telephone:
Email:
Affiliation:  University of Utah
Key inclusion & exclusion criteria

Inclusion Criteria:

- 10 patients with diagnosed EoE (greater than 20 eosinophils per HPF) on esophageal
biopsy will be included as the diseased population

- 7 controls (subjects without GI symptoms and known GI disease)

Exclusion Criteria:

- bleeding diathesis or contraindication to esophageal biopsies

- severe sleep apnea

- incarceration

- pregnancy

- inability to lie flat for 2 hours

- history of bleeding disorder

- Use of steroids

- Breast feeding

- Allergy to heparin or history of severe reaction to heparin

- allergy to mucomyst or severe asthma



Age minimum: 18 Years
Age maximum: 70 Years
Gender: All
Health Condition(s) or Problem(s) studied
Eosinophilic Esophagitis
Intervention(s)
Drug: Technetium Tc 99M
Radiation: Computerized Tomography scan
Procedure: Esophagogastroduodenoscopy
Radiation: Planar Images
Radiation: Single Photon Emission Computed Tomography scans
Primary Outcome(s)
Biodistribution of Tc99m-heparin [Time Frame: over approximately 24-26 hours]
Calculation of organ doses [Time Frame: over approximately 24-26 hours]
Secondary Outcome(s)
Secondary ID(s)
IRB_00058734
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history